STAT

AUGUST 19, 2024

He lamented last week how antitrust reviewers at Lina Khan’s Federal Trade Commission and Jonathan Kanter’s Antitrust Division at the Department of Justice are increasingly thwarting or stalling deals that have proliferated since the law went into effect in 2010.    Continue to STAT+ to read the full story…

Hospitals 361

Hospitals 361

STAT

JUNE 17, 2024

Perryman led the company from 2010 to 2019.  Under CEO Laura Perryman’s leadership, the company warped the design of their devices to earn more reimbursement money from insurers, resulting in unnecessary plastic parts that allowed doctors to claim around $18,000 more than they previously could. attorney Damian Williams.

338

338

STAT

SEPTEMBER 6, 2023

Congress previously drew this dubious distinction in 2010, when the biosimilar pathway it set up via the Biologics Price Competition and Innovation Act (BPCIA) conferred 12 years of data exclusivity on originator biologics, seven more than is given to originator small molecules under the Hatch-Waxman Act.

Biosimilars 335

Biosimilars Drug Pricing 335

STAT

MARCH 26, 2024

From 1919 to 1952, more than 20,000 nonconsensual sterilizations took place in that state; the law was not repealed until 1979 in state hospitals and, frighteningly, was still in effect in state prisons until 2010. Read the rest…

Hospitals 322

Hospitals 322

European Pharmaceutical Review

JULY 17, 2023

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 This was ~10 percent of reported industry spending. billion (3.3

Documentation 98

Documentation 98

STAT

MARCH 7, 2024

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

324

324

Drug Patent Watch

JULY 28, 2023

A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020.

97

97

STAT

DECEMBER 20, 2023

  Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million. 

335

335

STAT

SEPTEMBER 29, 2024

A Steward spokesperson did not say on Saturday if de la Torre will remain a major shareholder in the company he helped found in Boston in 2010. Continue to STAT+ to read the full story…

Hospitals 290

Hospitals 290

STAT

FEBRUARY 19, 2023

But I was totally unprepared for the constant exposure to widespread suffering and death that I experienced while providing emergency medical relief after the 2010 earthquake that killed 220,000 people in Haiti. Read the rest…

263

263

STAT

MARCH 26, 2024

Foundation, established in 2010 and later acquired by the Swiss drug giant Roche, had workers scattered among four locations, including its former headquarters in Cambridge.

Drug Development 274

Drug Development 274

STAT

MAY 8, 2023

That’s according to Gail Wilensky, who has been on the board of Geisinger since 2010. A long-running flurry of hospital and medical group acquisitions in Pennsylvania — especially among the giants UPMC and Highmark Health — forced Geisinger to make a bigger move of its own and to sell to Kaiser Permanente.

Hospitals 246

Hospitals 246

STAT

FEBRUARY 14, 2024

WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

237

237

STAT

JANUARY 10, 2023

The Food and Drug Administration approved 378 new drugs between 2010 and 2019, a big chunk of which were cancer medicines. The returns on biotech stocks were phenomenal.

Drug Development 255

Drug Development 255

STAT

JULY 6, 2023

business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. At the time, David Ricks was running Lilly’s U.S.

255

255

STAT

AUGUST 8, 2023

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010 , according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

246

246

STAT

AUGUST 23, 2023

When President Obama signed the ACA into law on March 23, 2010, reproductive health took a giant step forward with its commonsense yet revolutionary approach. Barbara Mikulski — fought for coverage of women’s preventive services like mammograms, cervical cancer screenings, prenatal care, and, yes, contraception.

240

240

STAT

SEPTEMBER 28, 2023

The FDA received more than 250 reports of patients experiencing suicidal thoughts or behaviors while taking Ozempic or similar medicines since 2010 , Reuters reports, citing an examination of the FDA adverse-event database. Thirty-six of these reports describe a death by suicide or suspected suicide.

290

290

EMCrit Project

MAY 16, 2024

In the early 2010's, a series of retrospective correlational studies found that patients treated […] EMCrit Project by Josh Farkas. Combine this with the conservatism that often (rightfully) surrounds drug safety, and it creates a lot of volatility. Before going further, we should review some recent history regarding piptazo.

108

108

Drug Patent Watch

JULY 27, 2023

Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity of Drugs Approved 2010–2019 and the Public Interest Protections of… The post DrugPatentWatch reveals NIH funding for patents appeared first on DrugPatentWatch - Make Better Decisions.

97

97

Express Pharma

MARCH 27, 2024

Established in 2010, Heads has operational presence in 25 multiple strategically important locations across Europe, North America and Asia Pacific region. Veeda Clinical Research has acquired Heads, a privately held European CRO, which specialises in conducting clinical trials in oncology.

111

111

Express Pharma

JUNE 24, 2024

Sun Pharma has been the majority shareholder of Taro since 2010. As part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates. As a result of the merger, Taro is now a private company and wholly owned by Sun Pharma.

95

95

pharmaphorum

MAY 6, 2021

McKenna has been with STEM since 2010, founding it in the US and Brazil before taking over the CEO role from co-founder Rob Wood in 2018. He will oversee the online performance marketing and digital benchmarking agency’s growth in the US joins Rob Wood and Barrie Brien on performance-io’s non-executive board.

119

119

Pharmaceutical Technology

AUGUST 28, 2022

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, is said to have infringed patents filed by Moderna between 2010 and 2016 for its mRNA technology. This technology was vital for developing Spikevax, an mRNA Covid-19 vaccine of Moderna.

Vaccines 98

Vaccines 98

The Guardian - Pharmaceutical Industry

AUGUST 24, 2024

The chancellor, Rachel Reeves, warns that hard choices on tax, spending and borrowing need to be made on 30 October when she delivers the first Labour budget since 2010, so poor is the economic legacy. The chancellor must step in Just how bad is the economy? Phooey, respond those still standing in the shredded Tory party.

90

90

ALiEM - Pharm Pearls

OCTOBER 7, 2024

2010 Dec;14(6):502-5. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29489275. Merino P, Gómez de Liaño P, Villalobo JM, Franco G, Gómez de Liaño R. Etiology and treatment of pediatric sixth nerve palsy. doi: 10.1016/j.jaapos.2010.09.009. 2010.09.009. PMID: 21168073.

161

161

Putting Patients First Blog

SEPTEMBER 7, 2023

However, the percentage of registrants using weekend (also called twice-weekly) dosing increased, with registrants born more recently (during or after 2010) being more likely to use a weekend dosing schedule than those who were born before 2010 (28% versus 9%).

Drug Pricing 111

Drug Pricing 111

ALiEM - Pharm Pearls

SEPTEMBER 15, 2023

Nat Rev Rheumatol 2010; 6:715. Repetitive motion occupations, tobacco use, alcohol use, and diabetes are key risk factors. References Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Trojian TH, Chu SM. Dupuytren’s disease: diagnosis and treatment. Am Fam Physician 2007; 76:86.

Diabetes 152

Diabetes Clinic Management 152

Pharmaceutical Technology

JUNE 12, 2023

Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010. In 2022, Pfizer acquired the drug, with the promise of accelerating clinical development via new, differentiated, and best-in-class approaches, enhancing optimism for further drug development.

Immunity 143

Immunity Immunization Drug Development 143

pharmaphorum

SEPTEMBER 24, 2020

The charges relate to a period from 2007 until the end of 2010, when the Department of Justice alleges California-based Gilead routinely obtained data from the foundation detailing how much the foundation had spent for patients on Letairis.

Drug Pricing 98

Drug Pricing 98

European Pharmaceutical Review

AUGUST 26, 2022

Moderna has filed patent infringement lawsuits alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty ® infringes patents Moderna filed between 2010 and 2016 covering its foundational messenger RNA (mRNA) technology.

Vaccines 98

Vaccines Immunity Immunization 98

European Pharmaceutical Review

DECEMBER 13, 2022

USP-NF Propylene Glycol Monograph: USP43-NF38, 2010, 3753. 5 Both compounds are limited to ≤0.1 percent or 1,000 ppm. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Ann Intern Med. 122(6); 1995: 456-461. FDA Guidance for Industry Testing of Glycerin for Diethylene Glycol. SCCP OPINION ON Diethylene glycol.

Compounding 105

Compounding Packaging 105

Pharmaceutical Commerce

JANUARY 25, 2024

Tesamorelin (Egrifta) was initially approved by the FDA in November 2010 for the treatment of lipodystrophy in patients also diagnosed with HIV.

52

52

Pharma Pathway

JANUARY 12, 2023

Ltd was incorporated in January 2010 and was founded by a group of experienced industry professionals. SunGlow Lifescience Pvt. Ltd-Openings for Production/ QC/ RA/ QMS/ ARD/ FRD/ Boiler Operator Dept. Job Description. SunGlow Lifescience Pvt. Our Corporate office is located in Chennai, Indian.

79

79

European Pharmaceutical Review

SEPTEMBER 18, 2023

Since 2010, the sector has secured eight percent growth each year. CGT Catapult aims to foster more connections, collaborations and partnerships between academia and industry to advance the sector, the organisation declared.

Vaccines 117

Vaccines 117

European Pharmaceutical Review

APRIL 2, 2024

Before joining Siegfried in 2010, Wienand worked at the German specialty chemicals company Evonik Industries, Lonza highlighted. Baehny has held his Chief Executive Officer ad interim role since October 2023 and will support Wienand through the transition period.

98

98

ALiEM - Pharm Pearls

OCTOBER 4, 2023

They were first developed in the 1950s by the Nazis and were used in chemical warfare in the Iran-Iraq War in the 1980s, by the Japanese Aum Shinrikyo cult in Tokyo, and in Syria in the 2010’s. The early “G series” agents such as soman, sarin, and tabun exist mostly in a vapor form.

Hospitals 195

Hospitals 195